| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| BUY | SELL | SELL | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 49.54▲ | 49.54▲ | 49.54▲ | 49.59▼ | 49.56▼ |
| MA10 | 49.54▲ | 49.55▼ | 49.55▼ | 49.60▼ | 49.57▼ |
| MA20 | 49.54▲ | 49.55▼ | 49.57▼ | 49.56▼ | 49.61▼ |
| MA50 | 49.57▼ | 49.59▼ | 49.59▼ | 49.60▼ | 49.72▼ |
| MA100 | 49.60▼ | 49.57▼ | 49.54▲ | 49.65▼ | 50.09▼ |
| MA200 | 49.58▼ | 49.58▼ | 49.59▼ | 49.73▼ | N/A |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.002▲ | 0.000▼ | -0.003▼ | 0.002▲ | 0.009▲ |
| RSI | 45.113▼ | 40.514▼ | 38.649▼ | 46.218▼ | 45.616▼ |
| STOCH | 41.667 | 8.333▼ | 13.095▼ | 50.660 | 42.762 |
| WILL %R | -25.000▲ | -70.000 | -75.000▼ | -73.333 | -60.241 |
| CCI | 164.706▲ | -44.444 | -72.532 | -72.310 | -31.212 |
|
Thursday, January 08, 2026 07:51 AM
Shares of Enliven Therapeutics (NASDAQ:ELVN) climbed 7% on Thursday after the company released positive early results from a Phase 1b study of its chronic myeloid leukemia (CML) drug candidate, ...
|
|
Thursday, January 08, 2026 06:16 AM
Enliven Therapeutics Inc. (NASDAQ: ELVN) stock is trading higher on Thursday, with a session volume of 6.61 million compared to the average volume of 631.52 thousand as per data from Benzinga Pro. The ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 28/01/26 | 49.55 | 49.59 | 49.521 | 49.55 | 164,500 |
| 27/01/26 | 49.59 | 49.59 | 49.54 | 49.54 | 44,600 |
| 26/01/26 | 49.561 | 49.61 | 49.54 | 49.60 | 70,400 |
| 23/01/26 | 49.65 | 49.65 | 49.61 | 49.63 | 42,800 |
| 22/01/26 | 49.61 | 49.66 | 49.59 | 49.64 | 31,600 |
| 21/01/26 | 49.61 | 49.65 | 49.57 | 49.61 | 59,500 |
| 20/01/26 | 49.65 | 49.65 | 49.588 | 49.62 | 36,300 |
| 16/01/26 | 49.62 | 49.63 | 49.58 | 49.63 | 128,800 |
| 15/01/26 | 49.60 | 49.60 | 49.57 | 49.581 | 37,600 |
| 14/01/26 | 49.59 | 49.59 | 49.55 | 49.565 | 69,600 |
|
|
||||
|
|
||||
|
|